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Abstract
Background: Progression of age-related macular degeneration hasb e e nl i n k e dt oi r o nd y s r e g u l a t i o na n do x i d a t i v e
stress that induce apoptosis of neural retinal cells. Since both antioxidants and chelating agents have been reported
to reduce the progression of retinal lesions associated with AMD in experimental animals, the present study evaluates
the ability of multi-functional antioxidants containing functional groups that can independently chelate redox metals
and quench free radicals to protect the retina against light-induced retinal degeneration, a rat model of dry atrophic
AMD.
Methods/Results: Proof of concept studies were conducted to evaluate the ability of 4-(5-hydroxypyrimidin-2-yl)-N,N-
dimethyl-3,5-dioxopiperazine-1-sulfonamide (compound 4) and 4-(5-hydroxy-4,6-dimethoxypyrimidin-2-yl)-N,N-di-
methyl-3,5-dioxopiperazine-1-sulfonamide (compound 8) to reduce retinal damage in 2-week dark adapted Wistar
rats exposed to 1000 lx of light for 3 hours. Assessment of the oxidative stress markers 4- hydroxynonenal and
nitrotyrosine modified proteins and Thioredoxin by ELISA and Western blots indicated that these compounds reduced
the oxidative insult caused by light exposure. The beneficial antioxidant effects of these compounds in providing
significant functional and structural protection were confirmed by electroretinography and quantitative histology of
the retina.
Conclusions/Significance: The present study suggests that multi-functional compounds may be effective candidates for
preventive therapy of AMD.
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Introduction
Age-related macular degeneration (AMD), the leading cause of
blindness in people over the age of 65 in the United States [1,2],
occurs in two major forms. The first is a geographic atrophy (‘dry’)
form that is defined by degeneration of photoreceptors and the
retinal pigmented epithelium (RPE) near the macula, the accumu-
lationoflipofuscin(A2E),andtheformationofdrusen.Thesecondis
a ‘wet’ form that is associated with choroidal neovascularization
(CNV) [3]. While a number of anti-neovascular agents are clinically
used to treat the CNV associated with the wet form of AMD, there
are no clinically approved agents to treat geographic atrophy, which
accounts for 45% of all advanced AMD cases [4].
Animal models currently used to identify and evaluate new
therapies for AMD include transgenic, immunized, and natural
murine models; laser photocoagulation and natural primate
models; and laser-induced neovascularization and light-induced
retinal damage rat models [3,5,6]. In the rat, light-induced retinal
degeneration mimics changes associated with late-stage, atrophic
retinal degeneration that include RPE ablation and photoreceptor
cell death [6]. Although the exact mechanism(s) of light-induced
photoreceptor damage have not been established, continuous
visible irradiation has been suggested to generate superoxide and
promote iron release from ferritin [7,8,9]. Together, the free iron
and superoxide anions can undergo the Haber-Weiss and Fenton
reactions to generate damaging hydroxyl radicals [10], that lead to
lipid peroxidation of retinal tissues [11,12,13] and plasma
membrane injury [12,14,15,16]. To prevent photoreceptor apop-
tosis associated with oxidative stress, both iron chelators, such as
desferrioxamine [17] that reduce the levels of free iron, and a wide
range of natural and synthetic antioxidants [18,19,20,21,22] have
been investigated.
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antioxidants, 4-(5-hydroxypyrimidin-2-yl)-N,N-dimethyl-3,5-diox-
opiperazine-1-sulfonamide and 4-(5-hydroxy-4,6-dimethoxypyri-
midin-2-yl)-N,N-dimethyl-3,5-dioxopiperazine-1-sulfonamide, la-
beled compounds 4 and 8, respectively [23] (Table 1). These
compounds contain both a unique 2-amino-5-hydroxy-1,3-pyrim-
idine free radical scavenger and the independent ability to
selectively chelate metal ions. Together, they reduced reduce
Fenton-generated reactive oxygen species (ROS)-induced RPE
damage in vitro [23]. Here, we report the first in vivo evaluation of
oral administration of compounds possessing this unique scaveng-
ing system with the independent ability to attenuate redox-active
metals in a light-induced retinal damage rat model. In this study,
retinal neuroprotection was assessed by the biochemical analyses
of oxidative stress parameters, functional analysis using electro-
retinography, and histology.
Materials and Methods
All reagents employed were of reagent grade. 4-(5-hydroxypyr-
imidin-2-yl)-N,N-dimethyl-3,5-dioxopiperazine-1-sulfonamide (4)
and 4-(5-hydroxy-4,6-dimethoxypyrimidin-2-yl)-N,N-dimethyl-
3,5-dioxopiperazine-1-sulfonamide (8) (99% pure by HPLC) were
synthesized as previously described [23]. Antibodies used: anti-
TRx (#2429; Cell Signaling Technology, Danvers, MA) 1:1000
and anti-TRxR (#ab16840; Abcam, Inc., Cambridge, MA)
1:2000. Chemiluminescent reagent and peroxide, biotinylated
protein ladder, and pre-stained protein marker were obtained
from Cell Signaling Technology (Danvers, MA). Polyacrylamide
Ready Gels (4–15% Tris-HCl) and Trans-BlotH nitrocellulose
membrane were obtained from Bio-Rad Laboratories (Hercules,
CA). OxiSelect
TM HNE-His Adduct and OxiSelect
TM Nitrotyr-
osine ELISA Kits were purchased from Cell Biolabs, Inc. (San
Diego, CA).
Animal Care
All procedures were performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
approved by the Institutional Animal Care and Use Committee of
UNMC (Permit Number: 09-039-05).
Oral Administration of Multi-functional Compounds
Four to five-week-old male Wistar rats (Charles River
Laboratories, Wilmington, MA), divided into three groups of 24
animals each, were maintained under total darkness for the
duration of the experiment except for twice daily checks under
dim red light (5 lx). One group was fed standard rodent chow
while the other two groups received standard rodent chow
supplemented with 0.05% of either compound 4 or 8 for the
duration of the experiment. Efficacy studies require the compar-
ison of an endpoint, such as ONL thickness, when both
compounds are administered at 50% of their effective dose
(ED50), which is not currently known. Therefore, the concentra-
tion of supplementation in diet (0.05%) was based on reports of
orally administered antioxidants that have been shown to reduce
light-induced retinal damage [19,20,24,25]. Rats received the
compound of interest in the diet rather than by gavage to
minimize the potential of effects due to half-life. Since rats tend to
eat while active, the administered dose is obtained over time rather
than a bolus dose. Rats were housed four to a cage and water was
provided ad libitum. Animal weight and food intake was measured
at 3–4 day intervals.
Light-induced Retinal Damage
After two weeks of dark adaptation, 12 rats from each group
were individually placed into acrylic, flat bottom rodent restraints
(Plas-Labs, Inc, Lansing, MI) in a light box apparatus and exposed
for three hours to 1000 lx of cool white fluorescent light (Lights of
America, Los Angeles, California) (light-damaged rats, LD). The
remaining 12 rats in each group were also placed into the light box
apparatus for three hours, but not exposed to light (non-light-
damaged rats, NLD). Oxidative stress markers were evaluated in 8
LD and 8 NLD rats of each group immediately after light
exposure. Following euthanasia, the neural retinas were carefully
dissected from the enucleated eye and frozen on dry ice. The
neural retina from the left eye was evaluated for neural retinal
levels of compounds while the right neural retina analyzed for
oxidative stress. For functional and morphological assessment, the
remaining 4 LD and 4 NLD rats in each group were returned to
the dark environment after exposure and retinal function was
assessed by ERG, 5 to 7 days later. Following ERG analysis, the
rats were euthanized and the enucleated eyes were immediately
processed for quantitative morphology.
Oxidative Stress Determination
Retinas were homogenized in lysis buffer (50 mM Tris HCl,
pH 7.5; 100 mM NaCl; 10 mM EDTA) for ELISA tests or in
RIPA buffer (Cell Signaling Technology, Danvers, MA) contain-
ing Halt Protease and Phosphatase Inhibitor Cocktail (VWR
International, West Chester, PA) for western blots. Total protein
concentrations of the retinal homogenates was determined by the
Bradford method [26]. Using the 4-HNE-His Adduct and
Nitrotyrosine ELISA Kits, modified protein levels were measured
according to manufacturer procedures except as follows. 4-HNE
levels were determined in 100 mL aliquot of retinal homogenate
(100 mg/mL) and nitrotyrosine-modified protein levels were
evaluated in a 50 mL aliquot of retinal homogenate (200 mg/
mL). Absorbance at 450 nm was read on a SpectraMax Plus
384
spectrophotometer (Molecular Devices, Sunnyvale, CA). The level
of HNE-protein adducts and nitrotyrosine-modified proteins were
determined from constructed standard curves. All assays were
performed in triplicate.
For western blots, protein samples were separated by SDS-
PAGE and transferred onto a nitrocellulose membrane. The
membrane was blocked with 5% dry milk in 0.1% TBST and
incubated overnight at 4uC with primary antibody. The
membranes were washed with TBS-T and incubated with a
HRP-conjugated secondary antibody for 1 hour. The specific
protein bands were visualized by chemiluminescence and exposure
to x-ray film, as determined by molecular weight markers.
Table 1. Properties of compounds 4 and 8 in vitro.
Compound Properties Compound 4 Compound 8
Cu (II) Binding Stoichiometry* 2.0 : 1.0 2.0 : 1.0
Fe (II) Binding Stoichiometry* 1.0 : 2.0 2.0 : 2.1
Zinc Binding Stoichiometry* 1.0 : 2.1 2.0 : 2.0
HLEC Viability
# 72% 75%
RPE Viability
# 75% 71%
*Stoichiometry (Compound : Metal Ion) of complexes formed in solution as
determined by Job Plots [23].
#Percent viable human lens epithelial cells (HLECs) and retinal pigmented
epithelium (RPE) cells after 2 hour exposure to 1 mM Fenton reagents (1 mM
H2O2 and Fe
2+) [23].
doi:10.1371/journal.pone.0021926.t001
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were performed using recombinant thioredoxin (#ab51064;
Abcam) and thioredoxin reductase (#ab95910; Abcam) protein
standards [unpublished data]. To ascertain the comparative
expression and equal loading of these protein samples, the
membrane was re-probed with antibody against GAPDH as an
internal control. The visualized protein levels were quantified
using the NIH ImageJ program (http://rsbweb.nih.gov/ij/).
Electroretinography (ERGs)
Each rat was prepared for ERG analysis under dim red light
illumination. Pupils were first dilated with 1% atropine sulfate
followed by anesthesia with an i.p. injection of ketamine (100 mg/
kg) and xylazine (20 mg/kg). A drop of 1% carboxymethylcellu-
lose was placed on the corneal surface of each eye to ensure
electrical contact and to maintain corneal integrity. This was
followed by the placement of the ERG electrodes (LKC
Technologies Inc., Gaithersburg, MD). A needle electrode, placed
under the skin of the forehead, served as ground. Body
temperature was maintained at 3860.3uC using a Themipaq
heating pad. ERG recordings were performed according to
Nystuen [27] using the UTAS system (LKC Technologies Inc.,
Gaithersburg, MD). Briefly, all stimuli generated were presented in
a Ganzfeld chamber/light emitter. Dark-adapted (scotopic)
responses were recorded over a 4.0 log unit range of intensities.
Light-adapted (photopic) responses were obtained with white
flashes (0.3 log unit step) after 10 min of exposure to the
background light to allow for complete light adaptation. Flicker
ERG analysis was not performed. The amplitude of the scotopic a-
wave was measured from baseline to the a-wave trough, while the
amplitude of the scotopic b-wave was measured from the trough of
the a-wave to the peak of the b-wave. The photopic b-wave
amplitude was measured from baseline to the b-wave peak.
Photoreceptor protection was determined by comparing the
average maximal amplitudes of the light-damaged rats from each
group to the non-light damaged rats of the same group.
Tissue Preparation
After ERG analysis, all animals were euthanized by carbon
dioxide asphyxiation and the dorsal ventral orientation of each eye
was marked with a cautery tool. The eyes were then enucleated
and fixed in a 3:1 (v/v) methanol: acetic acid solution overnight.
The fixed samples were then processed by the UNMC Tissue
Sciences Facility (http://www.unmc.edu/tissuesciences/).
Measurement of the Outer Nuclear Layer Thickness
Digital images of the H&E stained sections were obtained with a
Zeiss AxioPlan microscope (Carl Zeiss MicroImaging, Inc.,
Thornwood, NY) using Axiovision software. The outer nuclear
layer (ONL) thickness was measured at 400 mm intervals, starting
at the optic nerve head and extending toward the superior and
inferior ora serrata using Image-Pro Plus software (Media
Cybernetics, Silver Spring, MD).
Neural Retinal Levels of Compounds 4 and 8
Neural retinas were homogenized in a Pellet PestleH (Kimble
Chase, Vineland, NJ) with 0.5 mL of PBS containing 0.4 mM
N,N-Dimethyl-4-(pyrimidin-2-yl)piperazine-1-sulfonamide as the
internal standard. The homogenates were centrifuged at
10,000 rpm for 5 min at 4uC and the protein concentration in
an aliquot of the supernatant was determined according to
Bradford [26]. The remaining supernatant was then deproteinized
with equal volumes of zinc sulfate and barium hydroxide [28].
Following centrifugation at 10,000 g for 30 minutes at 4uC, the
supernatant was dried in vacuo and the residue was dissolved in
chloroform, filtered, and dried in vacuo. The remaining organic
residue containing the internal standard and extracted compounds
4 or 8 was dissolved in 250 mL of HPLC grade acetonitrile and
separated by reverse phase HPLC (Luna 5 mm C18, 25064;
Phenomenex Inc., Torrance, CA). The samples were eluted with
50% aqueous methanol. The eluent was monitored by UV at
247 nm and by ESI-MS on a Thermo Finnigan LCQ (Thermo
Fisher Scientific, Waltham, MA). Samples were quantified against
standard curves of compounds 4 and 8. All analyses were
conducted in triplicate.
Cell Culture
RGC-5 and 661wc ells were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM) media containing 10% fetal bovine
serum (FBS), 4 mM L-glutamine, 1.5 g/L NaHCO3, and 1%
penicillin/streptomycin solution. The cells were plated at a density
of 1610
4 cells into chamber slides or 96 well plates and grown
until 70–80% confluent. For compound evaluation, FBS-free
media (blank and control) or FBS-free media containing 1 mM of
either compound 4, 8 or Trolox, the water soluble vitamin E
analog, were added to each individual well/chamber. After 1 hr,
an additional aliquot of FBS-free media was added to each blank
well/chamber, and a similar volume of FBS-free media containing
concentrated H2O2 immediately followed by the addition of
concentrated ammonium iron (II) sulfate hexahydrate was added
to each well/chamber for a final concentration of 1 mM H2O2
and 1 mM Fe
2+. For apoptosis detection, all media was removed
after 4 h exposure and the cells were rinsed twice with PBS and air
dried. The cells were then fixed with freshly prepared 4%
paraformaldehyde in PBS, pH 7.4 for 1 h at room temperature.
After washing with PBS, the cells were treated with ice cooled
0.1% Triton X-100 in 0.1% sodium citrate, again rinsed.
Apoptosis was then detected by terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) assay,
using a fluorescein in situ cell death detection kit (Roche Applied
Science, Germany). The stained cells were then analyzed under a
fluorescence microscope and the apoptosis index was calculated as
the percentage of TUNEL-positive nuclei present in photographs
taken under 2006magnification in 5 to 10 fields in each well. For
cell viability studies, conducted in 96-well plates, media was
removed after 5 h exposure and the cells were rinsed twice with
PBS. The cells were then processed using the CellTiter 96H
AQueous One Solution Cell Proliferation Assay (MTS, Promega,
Madison, WI) as previously described [23].
Statistical Analyses
The calculations and statistical analyses (ANOVA) were
conducted using OriginProH software version 8.1 (OriginLab
Corp., Northampton, MA) and ProStat ver. 5.01 (Pearl River,
NY). Differences with a p,0.05 were defined as significant.
Results
Induction of Experimental Light Damage
Four to five-week-old male Wistar rats (Charles River
Laboratories, Wilmington, MA) were divided into three groups
of 24 animals each and dark adapted by maintaining them in total
darkness for two weeks except for twice daily examination under
dim red light (5 lx). All rats received standard rat chow; however,
one group received standard chow containing 0.05% wt%
compound 4 and a second group received standard chow
containing 0.05% wt% of compound 8. Feeding records indicate
Neuroprotection against Light-Induced Damage
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83.369.9 mg/kg/day (Mean6SEM), of compounds 4 and 8,
respectively, and no significant difference in body weights between
any group was observed. After two weeks of dark adaption, one
half of the rats from each group were individually placed into
acrylic rodent restraints and exposed to 1000 lx of cool white
fluorescent light for three hours (light damaged rats, LD). The
remaining rats in each group were also placed into the light box
apparatus for three hours, but not exposed to light (non-light-
damaged rats, NLD). One half of the LD and NLD rats in each
group were immediately analyzed for oxidative damage. The
remaining rats in each group were returned to the dim light
environment for 5–7 days for subsequent retinal functional
analysis.
Effects of Compounds 4 and 8 on 4-HNE- and
Peroxynitrite-mediated Protein Modifications in the
Neural Retina
Immediately after light exposure, oxidative stress markers were
evaluated in 8 LD and 8 NLD rats from each group. 4-
Hydroxynonenal (4-HNE), generated by the non-enzymatic
oxidation of n26 polyunsaturated fatty acids, forms adducts with
histidine (HIS) and can be used as a marker of oxidative stress
[29,30]. Analysis of these adducts by ELISA indicated that light
exposure significantly increased the levels of 4-HNE-modified
proteins in the neural retinas by 0.83 mg/mL (54%, P,0.05)
compared to untreated, NLD rats (Figure 1A). However, neural
retinal levels of 4-HNE did not significantly increase in light
treated rats receiving either compound 4 or 8.
Another oxidative marker is nitrotyrosine-modified proteins
which results from tyrosine residues being attacked by peroxyni-
trite, a strong oxidant formed by the reaction of nitric oxide with
superoxide anions that are generated by excessive light exposure
[9,31]. Analysis of nitrotyrosine modified protein levels in neural
retinas by ELISA indicated that light exposure significantly
increased nitrotyrosine levels by 44% (0.60 mg/mL, p,0.05)
compared to untreated, NLD rats. This increase in nitrotyrosine
levels was not observed in LD rats treated with either compound 4
or 8 (Figure 1B).
Effects of Compound 4 and 8 on Thioredoxin and
Thioredoxin Reductase Levels in the Retina
ROS and free radicals generated by retinal exposure to acute
excessive light is mediated by superoxide dismutase, glutathione
(GSH), and the thioredoxin (TRx)/thioredoxin reductase (TRxR)
defense system [32,33,34]. As illustrated in Figures 2 and 3, intense
light exposure induced the expression of both TRx and TRxR in
the neural retinas of untreated rats. This induction of TRx
reduced in the neural retinas of light exposed rats treated with
either compound 4 or 8 (Figure 2). A similar reduction was also
observed for the expression levels of TRxR (Figure 3).
Functional Assessment of the Rat Retina by
Electroretinography
In addition to generating ROS, intense light exposure
enhances lipid peroxidation of the photoreceptor outer segments
[11] which contributes to photoreceptor cell death [21,35].
Following 5–7 days of dark recovery from intense light exposure,
the retinal neural functions of the remaining rats in each group
(and their corresponding non-light damaged controls) were
evaluated by non-invasive electroretinography (ERG), a proce-
dure that measures the function of photoreceptors (rods and
cones), inner retinal cells (bipolar and amacrine cells), and
ganglion cells through the measurement of electrical responses
[36,37,38]. Representative waveforms of the maximal ERG
scotopic response from non-light damaged (left column) and light
damaged (right column) control (A,B), 4-treated (C,D), and 8-
treated (E,F) rats are illustrated in Figure 4. Compared to
untreated, NLD control rats, the average scotopic maximum a-
and b-wave amplitudes were significantly (p,0.05) reduced by
Figure 1. Comparison of 4-hydroxynonenal (HNE)-histidine adduct levels and nitrotyrosine adduct levels in the neural retina.
A. HNE-histidine adduct levels, as determined by ELISA, in rats treated with/without compounds 4 and 8 suggests that HNE levels were reduced by
treatment with multi-functional compounds. B. Similar conclusions were obtained with ELISA measurements of nitrotyrosine-modified proteins in
rats treated with/without compounds 4 and 8. Mean 6 S.D.; n=6. An asterisk (*) denotes a significant difference (p,0.05) when compared to the
untreated, non light-damaged (NLD) group.
doi:10.1371/journal.pone.0021926.g001
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(Figure 5). This reduction in the scotopic maximum a- and b-
wave amplitudes was absent in LD rats treated with compounds 4
and 8. Furthermore, the NLD rats treated with compounds 4 and
8 displayed similar scotopic ERG responses (Figure 5), suggesting
that in addition to protecting the retina against light damage,
these compounds demonstrated no toxic effects that damage to
the retina at the levels present (Figure 6). Representative
waveforms of the maximal ERG photopic response from non-
light damaged (left column) and light damaged (right column)
control (A,B), 4-treated (C,D), and 8-treated (E,F) rats are
illustrated in Figure 7. In the photopic ERG b-wave response,
untreated LD rats demonstrated a significant (24.7%, p.0.05)
reduction in maximal amplitude compared to untreated, NLD
rats (Figure 8). Compared to the untreated LD rats, the photopic
b-wave response of LD rats treated with compound 8 was only
slightly reduced, while the b-wave amplitude from rats treated
with compound 4 was similar to that of untreated, NLD rats
(Figure 8). The b-wave amplitudes of NLD rats treated with 4-
treated and 8-treated were also similar to that of untreated NLD
rats (Figure 8), confirming that compounds 4 and 8 do not appear
to be toxic to the neural retina.
Figure 2. Expression of thioredoxin (TRx) in the neural retina. Top: Comparison of expression of TRx normalized to levels of GAPDH in rats
treated with/without compounds 4 and 8 suggest that treatment with multi-functional compounds reduce induction of TRx. Retinal protein
homogenate was subjected to Western blotting with anti-TRx and anti-GAPDH antibodies. Bottom: Lanes 1, control diet, non light-damaged; Lane 2,
control diet, light-damaged; Lane 3, 4-treated, non light-damaged; Lane 4, 4-treated, light-damaged; Lane 5, 8-treated, non light-damaged; Lane 6,
8-treated, light-damaged. Lanes of interest were cropped from entire western blot scan prior to be auto leveled using Adobe Photoshop and
analyzed by ImageJ software. Mean 6 S.D.; n=6. An asterisk (*) denotes a significant difference (p,0.05) when compared to the untreated, non light-
damaged group. A double dagger ({) denotes a significant difference (p,0.05) when compared to the untreated, light-damaged group.
doi:10.1371/journal.pone.0021926.g002
Figure 3. Expression of thioredoxin reductase (TRxR) in the neural retina. Top: Comparison of expression of TRxR normalized to levels of
GAPDH in rats treated with/without compounds 4 and 8 suggest that treatment with multi-functional compounds reduce induction of TRxR. Retinal
protein homogenate was subjected to Western blotting with anti-TRxR and anti-GAPDH antibodies. Bottom: Lanes 1, control diet, non light-
damaged; Lane 2, control diet, light-damaged; Lane 3, 4-treated, non light-damaged; Lane 4, 4-treated, light-damaged; Lane 5, 8-treated, non light-
damaged; Lane 6, 8-treated, light-damaged. Lanes of interest were cropped from entire western blot scan prior to be auto leveled using Adobe
Photoshop and analyzed by ImageJ software. Mean 6 S.D.; n=6. An asterisk (*) denotes a significant difference (p,0.05) when compared to the
untreated, non light-damaged group. A double dagger ({) denotes a significant difference (p,0.05) when compared to the untreated, light-damaged
group.
doi:10.1371/journal.pone.0021926.g003
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Damage by Quantitative Histology
The observation that rats treated with either compound 4 or 8
showed a decrease in oxidative stress, leading to little or no loss of
retinal function was confirmed by histology. Intense light exposure
results in photoreceptors thinning in the outer nuclear layer
(ONL), with damage in the superior hemisphere more pronounced
than the inferior hemisphere [6]. Retinal sections transversing the
optic nerve head were prepared from rats in each group and the
thickness of the ONL of the retina was measured from the optic
nerve head to the inferior and superior ora serratas using image
analysis software. Example high magnification images of the
retinal sections taken one millimeter superior and one millimeter
inferior to the optic nerve head for each group are illustrated in
Figure 9.
Histological evaluation of the ONL indicated a significant 40%
(p,0.05) thinning of the photoreceptor layer in the inferior
hemisphere and a 62% (p,0.05) thinning in the superior
hemisphere (Figure 10) compared to NLD rats. This light induced
thinning of the ONL was significantly (p,0.05) reduced in LD rats
treated with compounds 4 and 8. Compared to untreated LD rats,
the ONL was reduced 26% in the inferior and 35% in the superior
Figure 4. Dark-adapted (scotopic) ERG responses. Representative average maximal ERG scotopic response from untreated, control rats (A,B),
4-treated rats (C,D), and 8-treated rats (E,F). The a-wave was measured from baseline to trough, while the b-wave was measured from the trough of
the a-wave to the peak of the wave.
doi:10.1371/journal.pone.0021926.g004
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rats treated with compound 4, the photoreceptor layer was
decreased 4% in the inferior hemisphere and 21% in the superior
hemisphere (Figure 10). In the NLD rats no difference in ONL
thickness was observed between the untreated and compound 4 or
8 treated rats confirming that these compounds are not phototoxic
(Figure 10).
These histological results complement the ERG studies by
confirming that oral administration of compounds 4 or 8 reduced
oxidative stress generated by light damage and protected the
structure and function of the retina. Evaluation of retinal levels of
drug in select rats from each group revealed that compounds 4 and
8 achieved neural retina levels of 770690 ng/mg protein and
1210675 ng/mg, respectively (Mean6SEM) (Figure 6). While in
vitro culture studies showed compounds 4 and 8 to be equipotent,
the better protective effects of compound 4 combined with its
lower retinal tissue levels suggests that compound 4 is more potent
that compound 8 in vivo.
Effects of Compound 4 and 8 on Cell Viability and TUNEL
Staining in vitro
While we have previously demonstrated the efficacy of these
multi-functional compounds in a human lens epithelial cell line,
human retinal pigmented epithelial cell line and a human
hippocampal astrocyte cell line [23], the present neuroprotective
studies are focused on the photoreceptor layer. To confirm that
these multifunctional compounds also protect retinal cells
associated with this layer, in vitro cultured rat ganglion RGC-5
cells and murine 661w photoreceptor cells were cultured in the
presence of 1 mM Fenton reagents (1 mM H2O2 and 1 mM Fe
2+)
with/without the water-soluble a-tocopherol analog Trolox,
compound 4 or compound 8. As summarized in Figure 11,
multi-functional compounds 4 and 8 provided Trolox-equivalent
protection against apoptosis, as measured by the TUNEL assay
(Fig 11A), and Trolox-superior protection of the photoreceptor
cells, as measured by the MTS cell viability assay (Fig. 11B).
Discussion
Light-induced retinal degeneration in animals has been
extensively used to evaluate neuroprotective candidates for the
treatment of retinal degenerations such as AMD because light-
damaged photoreceptors undergo oxidation-induced apoptosis
similar to that observed in AMD [39,40]. An important
mechanism in light-induced retinal injury is hydroxyl radical-
mediated lipid peroxidation that is propagated through Haber-
Weiss and Fenton reactions catalyzed by iron or copper
[10,11,41,42]. Since these reactive oxygen species are short lived,
this has been indirectly confirmed through the use of antioxidants
[18,19,20,21,22] and chelating agents, such as desferrioxamine
[17], both of which demonstrate some effectiveness in amelio-
rating retinal damage in vivo. The multi-functional antioxidants,
4-(5-hydroxypyrimidin-2-yl)-N,N-dimethyl-3,5-dioxopiperazine-1-
sulfonamide (4) and 4-(5-hydroxy-4,6-dimethoxypyrimidin-2-yl)-
N,N-dimethyl-3,5-dioxopiperazine-1-sulfonamide (8) used in the
present study have the independent ability to both attenuate
redox-active metals and scavenge free radicals. In vitro they
reduced ROS-induced human RPE damage and selectively
chelated iron or copper (Table 1). These compounds contain a
newly described 2-amino-5-hydroxy-1,3-pyrimidine free radical
scavenging system [43] and, to our knowledge, this is the first in
vivo study that uses this unique radical scavenging system and the
first in vivo study to demonstrate a protective effect of an orally
active combination metal chelator and free radical scavenger on
light-induced retinal degeneration. While it is well-established that
light damage to the photoreceptor layer results from the
generation of ROS and the subsequent release of free iron from
the degenerating photoreceptors, the present study could not
determine the relative contributions of free radical scavenging
Figure 5. Percent dark-adapted ERG response. The mean (6S.E.M) of the maximal scotopic a-wave and b-wave amplitudes for non light-
damaged and light-damaged eyes are shown as a percent of the maximal amplitude from untreated, non light-damaged rats (100% response). n=6
rats. An asterisk (*) denotes a significant difference (p,0.05) when compared to the untreated, non light-damaged group.
doi:10.1371/journal.pone.0021926.g005
Figure 6. HPLC-MS analysis of neural retinal levels of 4 and 8.
Analysis confirms accumulation of investigational compounds 4 and 8
in the neural retina following two week feeding of diet supplemented
with 0.05% compounds 4 and 8. Mean 6 S.E.M.; n=6. The pound (#)
sign denotes a significant difference (p,0.05) when compared to the
4-treated group.
doi:10.1371/journal.pone.0021926.g006
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To determine the detailed importance of these two factors, new
experiments utilizing analogs with only chelating or free radical
scavenging activity as described by Jin et al [23] will have to be
conducted.
Unlike many metal binding compounds, these multi-functional
antioxidants are orally bioavailable. This is advantageous because
oral administration is associated with high patient compliance. In
the absence of detailed pharmacokinetic data, rats in the present
study were administered compounds 4 and 8 in standard rodent
diet to minimize drug elimination effects. Since rats continuously
eat when active, they were continuously receiving drug. Wistar rats
were utilized in the present study because they are more sensitive
to light-damage compared to Sprague Dawley rats [24]. The
intensity and duration of light exposure was based on reports that
a 3 hour exposure to 1000 lx of significantly reduces ERG
response in dark-adapted rats without completely abolishing the
photoreceptor layer [24].
Since the rats were preloaded with compounds 4 and 8 in the
present study prior to light exposure to ensure that adequate
compound was present in the retina, these studies are prevention
rather than intervention studies. Moreover, the concomitant
preloading of compounds 4 and 8 in the dark controls represent
a quick assessment of toxicity since potential phototoxicity of these
Figure 7. Light-saturated (photopic) ERG responses. Representative average maximal ERG photopic response from untreated, control rats
(A,B), 4-treated rats (C,D), and 8-treated rats (E,F). The b-wave was measured from baseline to the peak of the wave.
doi:10.1371/journal.pone.0021926.g007
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controls treated with / without compounds. To determine
intervention efficacy, these studies will have to be repeated with
the compounds administered at time points from the time of
photodamage to select periods after the light insult.
The retina is sensitive to oxidative stress and the persistent
oxidative stress generated during light exposure initiates modifi-
cation of retinal proteins by HNE and peroxynitrite [11,41].
Consistent with previously published results [30], protein modi-
fication by 4-HNE and peroxynitrite was significantly increased
following 3 hour exposure to 1000 lx of light. The modification of
retinal proteins immediately following oxidative insult was
effectively inhibited by oral administration of compounds 4 and
8. Since treatment with compounds 4 and 8 reduced the end
products of lipid peroxidation, it can be deduced that both of these
compounds reduced the oxidative burden in the retina immedi-
ately following light-damage. These in vivo results support our
findings in vitro [23].
Thioredoxin (TRx) defends against cellular oxidative damage
by scavenging oxidative stress generated by ROS [32]. It is actively
induced in the mitochondria of RPE cells upon oxidative stress,
including acute light-induced injury [33]. Similarly, thioredoxin
reductase (TRxR), has been shown to be induced under conditions
of persistent oxidative stress [44]. The TRx/TRxR defense sys-
tem helps combat ROS and free radicals produced in the neural
retina by the acute exposure to light [45]. In the present study, the
Figure 8. Percent light-saturated ERG response. The mean (6S.E.M) of the maximal photopic b-wave amplitude for non light-damaged and
light-damaged eyes are shown as a percent of the maximal amplitude from untreated, non light-damaged rats (100% response). n=6 rats. An asterisk
(*) denotes a significant difference (p,0.05) when compared to the untreated, non light-damaged group. A pound sign (#) denotes a significant
difference (p,0.05) when compared to the light-damaged, 4-treated group.
doi:10.1371/journal.pone.0021926.g008
Figure 9. Histological sections of the ONL. Representative microscope images taken at 1 mm inferior and superior to the ONH of H&E stained
sections through the optic nerve of retinas treated with/without compounds 4 and 8. Left: Non light-damaged (2) retinas treated with/without
compounds 4 and 8. Right: ONL thickness of light-damaged (+) retinas treated with/without compounds 4 and 8. The white point (background) in
each image was set using Adobe Photoshop prior to analysis of ONL thickness using Image-Pro Plus software.
doi:10.1371/journal.pone.0021926.g009
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TRx and TRxR in LD rats. In LD rats pretreated with 4 and 8,
TRx induction was partially reduced, but not to basal levels
(NLD). The expression of TRxR followed a similar trend. This
data suggests that compounds 4 and 8 reduced the presence of
oxidative stress in the neural retina during and immediately
following acute exposure to light.
Rod outer segments in the photoreceptor layer of the retina are
rich in polyunsaturated fatty acids, which are most vulnerable to
lipid peroxidation [46]. Lipid hydroperoxide accumulates in rat
rod outer segments when exposed to constant illumination [42].
Lipid peroxidation in the rod outer segments leads to disruptions
of the surrounding plasma membranes and cellular material
escaping into the subretinal space [47]. The outer segments of
cones are more susceptible to damage than rod outer segments.
Following light-induced damage, ultrastructural changes such as
an increase in the degree of waviness of the discs, breaks in the disc
stacking, and complete disorientation of the discs in the cone outer
segments have been observed [47]. While light damage to the rods
and cones in the photoreceptor layer cannot be detected by
ophthalmoscope, even at a time when animals are functionally
blind [48], early changes can be detected by electroretinography
(ERG) [48,49]. In untreated, LD animals, a reduction of the
maximal amplitudes of the scotopic a- and b-wave and the
photopic b-wave response was observed. ERG scotopic and
photopic responses were normalized in light-damaged rats by pre-
treatment with compound 4. Pre-treatment with compound 8 was
able to retain similar maximal scotopic a-wave and b-wave
amplitude, but did not completely protect the maximal photopic
b-wave amplitude. Differences in in vivo efficacy of compound 8
between reduction of oxidative stress markers and maintenance of
ERG signal could be due in part to reduced protection of the
photoreceptors from secondary damage during the 5 to 7 days post
light damage. No difference in ERG response in NLD animals
treated with/without compound 4 or 8 was observed, suggesting
that these compounds are not neurotoxic to the retina. These
Figure 10. Retinal outer nuclear layer (ONL) thickness. The ONL thickness of the inferior and superior hemispheres was measured in mma t
each defined distance from the optic nerve. Top: ONL thickness of non light-damaged (2) retinas treated with/without compounds 4 and 8. Bottom:
ONL thickness of light-damaged (+) retinas treated with/without compounds 4 and 8. n=3. Mean 6 S.E.M. An asterisk (*) denotes a significant
difference (p,0.05) when compared to the untreated, light-damaged group.
doi:10.1371/journal.pone.0021926.g010
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the ONL occurred in untreated, LD animals, with the superior
hemisphere displaying more pronounced damage than the inferior
hemisphere. In similar rats treated with compounds 4 and 8, the
light-induced thinning of the inferior and superior hemispheres of
the ONL was significantly reduced, with compound 4 protecting
better than compound 8. Even though levels of compound 4 in the
neural retina were lower than that of compound 8, thinning of the
ONL was significantly less in 4-treated animals. Interestingly, rats
treated with compound 8 demonstrated good ERG responses
(Figures 5 and 8) despite greater histological damage compared to
that seen in rats treated with compound 4 (Figures 9 and 10). Light
damage is generally more severe in the superior versus the inferior
hemisphere, as confirmed in the present study. Since the ONL
damage was less in rats treated with compound 8 compared to the
untreated light damaged controls, we conclude that the minimum
number of photoreceptors to give a good ERG response must have
been retained by the 8-treated rats and that these signals
predominantly came from the inferior hemisphere.
Since compounds 4 and 8 demonstrated similar in vitro activity
[23] and protection against acute oxidative insult, further studies
are required to explain the in vivo efficacy observed. While levels of
compound 8 were higher in the retina, this level was not toxic to
the photoreceptors, as indicated by both 8-treated, NLD ERG
responses and histology. The morphological evaluation of retinal
damage confirmed the ERG results that multi-functional com-
pounds 4 and 8 demonstrate neuroprotection. The average
thickness of the ONL across the entire retinal expanse in NLD
rats treated with/without compounds 4 and 8 was 30–35 mm with
no significant difference between groups. This average thickness is
less than that reported for Wistar pups born under dim cyclic light
(40–45 mm) [24], suggesting that normal light exposure of these
very light-sensitive rats prior to the onset of this study had already
reduced ONL thickness. While it would have been ideal to wean
our own Wistar pups under dim cyclic light to avoid this
difference, this was not feasible to perform at UNMC at the time
of these studies. Nevertheless, these studies remain valid because
light exposure to the untreated dark adapted rats resulted in
significant oxidative, ERG and histological changes that were
absent in the similar dark maintained controls.
For the biochemical analysis of oxidative stress and drug levels,
neural retinas were obtained and frozen immediately following
light exposure. The neural retina from each left eye was evaluated
for drug levels in the neural retina while the right neural retina was
analyzed for oxidative stress. Due to the potential for protein
degradation, the retinas of these rats were not perfused with PBS
to remove blood from the neural retina. Since this can result in
high retinal drug levels due to the present of drug in the blood,
additional studies on two week oral administration of compounds
4 and 8 have been conducted (data not shown). PBS perfusion of
the animals under anesthesia resulted in a 20% reduction of neural
retina drug levels obtained. This does not invalidate our
conclusion that the observed biochemical, physiological and
morphometric results are linked to the presence of compound in
the neural retina.
In our previous in vitro study, multi-functional compounds 4
and 8 reduced ROS-induced damage to human RPE cells, a cell
type instrumental in the development of age-related macular
degeneration [23]. AMD is a complex disease whose progression is
linked to ROS, primarily H2O2, and the age-related accumulation
of redox active metals [50,51]. This Fenton-catalyzed oxidative
stress is believed to trigger biochemical cascades that lead to
progressive degeneration [51,52]. This hypothesis has been
indirectly confirmed by the effectiveness of the metal chelator,
deferiprone, to reduce iron overload-induced retinal damage in a
transgenic mouse model [53] and desferrioxamine’s ability to
protect against light-induced retinal damage [17], presumably by
chelating iron released from ferritin by light [7]. Therefore, it was
hypothesized that multi-functional antioxidants 4 and 8 should be
neuroprotective in a rat model of light-induced retinal damage.
While these compounds have the independent ability to scavenge
free radicals and chelate metals, the present study only
demonstrates total antioxidant ability (metal chelation plus
scavenging free radicals) of these multi-functional compounds to
protect the photoreceptor layer against intense oxidative-induced
apoptosis. To determine the relative importance of free radical
scavenging versus metal attenuation, future studies using com-
pounds possessing only free radical scavenging or metal chelation
ability as described by Jin et al are required [23]. The present
study suggests that multi-functional compounds may be effective
Figure 11. Protective effects of compounds 4, 8 and Trolox against Fenton-generated ROS. A. Protection against apoptosis detected by
TUNEL staining of retinal ganglion RGC-5 cells cultured for 4 h in oxidative conditions generated by 1 mM H2O2 and 1 mM Fe(II). Mean 6 SD, n=4.
B. Cell viability detected by the spectrophotometric MTS assay of 661w photoreceptor cells after 5 hr exposure to ROS generated by 1 mM H202 and
1 mM Fe(II). Mean 6 SD, n=6.
doi:10.1371/journal.pone.0021926.g011
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investigation in other animal models of AMD is required.
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